Tags : Immuneering

Evotec and Immuneering Collaborates to Develop Novel Candidates for Rare

 Shots: The collaboration is a focus of combining Evotec’s stem cell (“iPSC”) platform with Immuneering’s Artificial Intelligence drug discovery platform for development of therapies Additionally, Immuneering’s AI platform fluency will assist in analyzing public and proprietary data, for identification of novel candidates AI platform is a drug discovery based technology used to discover & develop […]Read More